Pfizer Beats In Q1 But Lyrica Headwinds Will Likely Weigh On Near Term Growth

Pfizer (NYSE:PFE) recently reported its Q1 2019 results, which were above our estimates. This note details the company's Q1 performance, and Trefis' forecast for the full year 2019. You can view our interactive dashboard analysis ~ How Did Pfizer Fare In Q1, And What Can We Expect From Full Year ...